Clinical Trials Logo

Clinical Trial Summary

Investigate the safety and efficacy of multi-channel gastric electrical stimulation in the treatment of patients with severe diabetic gastroparesis refractory to standard therapy.


Clinical Trial Description

Evaluation of severe symptom control of nausea, vomiting, postprandial fullness, early satiety, bloating and discomfort related to drug refractory gastroparesis present as a GI complication in diabetic patients. External gastric pacemaker system will be placed at the same time of implantation of Enterra (internal gastric stimulator-permanent device) to assess symptoms, quality of life improvement and investigate the changes in gastric emptying time in diabetic gastroparesis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00595621
Study type Interventional
Source University of Kansas Medical Center
Contact
Status Completed
Phase N/A
Start date February 2006
Completion date June 2009

See also
  Status Clinical Trial Phase
Completed NCT05573854 - Residual Gastric Volume After the Ingestion of Supplements Containing Carbohydrates and Whey Protein N/A